Brief: Embecta Q3 Revenue USD 272.5 Million Vs. IBES Estimate USD 267.4 Million
09/08/2024 11:30
Aug 09 (Reuters) - Embecta Q3 dividend USD 0.15. * Q3 adjusted gross profit USD 190.3 million * Q3 adjusted operating income USD 83.3 million vs. IBES estimate USD 62.9 million * Q3 gross profit USD 190.1 million * Q3 adjusted EBITDA USD 99.2 million * Q3 operating income USD 55.9 million
Recent news on Embecta
See all newsEmbecta Corp. reports results for the quarter ended June 30 - Earnings Summary
Brief: Embecta Reports Third Quarter Fiscal 2026 Financial Results
Brief: Embecta Outlook FY Adjusted EPS USD 0.27 Vs. IBES Estimate USD 1.59
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel